Cholera epidemic amidst the COVID-19 pandemic in Moroto district, Uganda: Hurdles and opportunities for control.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
02
2022
accepted:
20
09
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
On 21st March 2020, the first COVID-19 case was detected in Uganda and a COVID-19 pandemic declared. On the same date, a nationwide lockdown was instituted in response to the pandemic. Subsequently, more cases were detected amongst the returning international travelers as the disease continued to spread across the country. On May 14th, 2020, a cholera epidemic was confirmed in Moroto district at a time when the district had registered several COVID-19 cases and was in lockdown. This study aimed to describe the cholera epidemic and response activities during the COVID-19 pandemic as well as the hurdles and opportunities for cholera control encountered during the response. In a cross-sectional study design, we reviewed Moroto district's weekly epidemiological records on cholera and COVID-19 from April to July 2020. We obtained additional information through a review of the outbreak investigation and control reports. Data were analyzed and presented in frequencies, proportions, attack rates, case fatality rates, graphs, and maps. As of June 28th, 2020, 458 cases presenting with severe diarrhea and/or vomiting were line listed in Moroto district. The most affected age group was 15-30 years, 30.1% (138/458). The females, 59.0% [270/458], were the majority. The Case Fatality Rate (CFR) was 0.4% (2/458). Whereas home use of contaminated water following the vandalization of the only clean water source in Natapar Kocuc village, Moroto district, could have elicited the epidemic, implementing COVID-19 preventive and control measures presented some hurdles and opportunities for cholera control. The significant hurdles were observing the COVID-19 control measures such as social distancing, wearing of masks, and limited time in the community due to the need to observe curfew rules starting at 6.00 pm. The opportunities from COVID-19 measures complementary to cholera control measures included frequent hand washing, travel restrictions within the district & surrounding areas, and closure of markets. COVID-19 preventive and control measures such as social distancing, wearing of masks, and curfew rules may be a hurdle to cholera control whereas frequent hand washing, travel restrictions within the district & surrounding areas, and closure of markets may present opportunities for cholera control. Other settings experiencing concurrent cholera and COVID-19 outbreaks can borrow lessons from this study.
Identifiants
pubmed: 36962556
doi: 10.1371/journal.pgph.0000590
pii: PGPH-D-22-00295
pmc: PMC10022206
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000590Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright: © 2022 Orishaba et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118
pubmed: 29284003
PLoS Negl Trop Dis. 2013 Dec 05;7(12):e2545
pubmed: 24340106
Am J Trop Med Hyg. 2007 Oct;77(4):705-13
pubmed: 17978075
Int J Health Plann Manage. 2021 Nov;36(6):2030-2034
pubmed: 34296467
J Med Virol. 2021 Jul;93(7):4090-4091
pubmed: 33749830
J Appl Microbiol. 2014 Feb;116(2):447-63
pubmed: 24127653
Nature. 2021 Apr;592(7853):173-174
pubmed: 33785930
BMC Med. 2022 May 2;20(1):167
pubmed: 35501853
Epidemiol Infect. 2012 Aug;140(8):1376-85
pubmed: 21943798
PLoS One. 2015 Aug 18;10(8):e0135676
pubmed: 26284367
One Health. 2019 Jan 09;7:100080
pubmed: 30671528
PLoS Negl Trop Dis. 2018 Jun 4;12(6):e0006492
pubmed: 29864113